Cell viability assays indicated that CAF/CM-induced chemoresistance to cisplatin in bladder cancer cells was significantly blocked after CXCL14 was intervened in CAFs (Fig. 3I, L and Fig. S3 O, P). This evidence concerns the gene CXCL14 and urinary bladder cancer.